Dysfunctional Telomeres, Checkpoints and Aging
Dysfunctional Telomeres, Checkpoints and Aging
批准号:
7653672
负责人:
Kwok Kin Wong
金额:
$26.99万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-09-30 至 2011-08-31
关键词:
AccelerationAgeAgingAging-Related ProcessAllelesApoptosisAutopsyBiologicalBiological ModelsBreedingCell AgingCell Culture TechniquesCell DeathCell divisionCellsChickensChromosomal RearrangementChromosomesComplexDNADataDoctor of MedicineDoctor of PhilosophyEngineeringEventFailureFunctional disorderGene DosageGenerationsGenesGeneticGenomeGenome StabilityGenomic InstabilityGenotypeHistocompatibility TestingHomeostasisIn VitroIncidenceLengthLightLinkLongevityMalignant NeoplasmsModelingMolecularMolecular CytogeneticsMolecular GeneticsMusMutant Strains MiceMutationOrganOrgan failureOxidative StressPathologicPathway interactionsPhenotypePhysiologicalPlayPopulationPremature aging syndromePreventionProcessReadingReserve Stem CellRoleSeriesSignal TransductionStagingStem cellsStructureTP53 geneTamoxifenTelomeraseTelomere MaintenanceTelomere ShorteningTestingTherapeutic InterventionTimeTissuesTumor SuppressionUpper armWorkanimal tissuebasebeta Actinbody systemcancer genomecarcinogenesiscell typecellular targetingcohortexhaustin vivoinsightmouse modelmutantmutant mouse modelpreventreconstitutionresponsesenescencestemtelomeretumor progressiontumorigenesis
中文摘要
描述(申请人提供):端粒是染色体上特殊的顶端结构,在衰老、癌症和基因组稳定方面发挥重要作用。随着细胞的每次分裂,端粒逐渐变短,当达到关键阶段时,它们会发出信号让细胞停止分裂。这一过程可能会防止细胞获得可能导致癌症或衰老的突变。当调节端粒维持或检查点反应的关键基因(如p53和ATM)发生突变时,端粒就会变得严重缩短和功能失调。我们最近的发现将端粒功能障碍与联合端粒酶ATM突变小鼠模型中的前体/干细胞耗尽和加速衰老联系起来,为探索端粒功能障碍导致衰老、器官动态平衡和肿瘤发生的分子机制提供了一个独特的机会和遗传平台。我们假设,由于mTerc和ATM缺陷而导致端粒极度短小和检查点反应缺陷的小鼠将更容易加速衰老或肿瘤发生,这取决于P53的状态。我们还认为,这些小鼠不同器官间端粒酶活性的重建将取决于重建时基因组的状态,要么强烈促进器官特异性肿瘤的进展,要么挽救器官干细胞/祖细胞耗竭的表型,同时抑制肿瘤的发生。最后,对加速衰老和前体/干细胞耗竭的复合突变小鼠的原代细胞和组织中导致P53功能激活的途径的详细分子特征将剖析参与衰老过程和器官动态平衡的分子途径。
英文摘要
DESCRIPTION (provided by applicant): Telomeres are specialized capping structures on chromosomes that play important roles in aging, cancer and genome stability. With each cell division, telomeres progressively shorten such that upon reaching a critical stage, they signal cells to stop dividing. This process likely prevents cells from acquiring mutations that may result in cancer or aging. When mutations occur in crucial genes that regulate telomere maintenance or checkpoint responses (such as p53 and ATM), telomeres become critically shortened and dysfunctional. Our recent findings linking telomere dysfunction to precursor/stem cell depletion and accelerated aging in the combined telomerase Atm mutant mouse model provide a unique opportunity and genetic platform to explore the molecular mechanisms by which telomere dysfunction contributes to aging, organ homeostasis and tumorigenesis. We hypothesize that mice engineered to have critically short telomeres and defective checkpoint responses due to mTerc and Atm deficiency will be predisposed to either accelerated aging or tumorigenesis depending on p53 status. We also believe that reconstitution of telomerase activity in different organ compartments of these mice will, depending on the state of the genome at the time of the reconstitution, either strongly promote organ specific tumor progression or rescue the organ stem/progenitor cell depletion phenotype as well as suppressing tumorigenesis. Lastly, detailed molecular characterization of pathways leading to activation of p53 function in primary cells and tissues from these compound mutant mice with accelerated aging and precursor/stem cell depletion will dissect the molecular pathways that are involved in the process of aging and organ homeostasis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Therapeutic strategies for specific subsets of KRAS mutant lung cancers
-
批准号:9451116
-
项目类别:
-
资助金额:$55.92万
-
财政年份:2017
-
负责人:Kwok Kin Wong
-
依托单位:
Animal Models/Experimental Therapeutics Core
-
批准号:8237138
-
项目类别:
-
资助金额:$8.71万
-
财政年份:2012
-
负责人:Kwok Kin Wong
-
依托单位:
Core C: Animal Modeling and Preclinical Therapeutics
-
批准号:10231104
-
项目类别:
-
资助金额:$26.38万
-
财政年份:2012
-
负责人:Kwok Kin Wong
-
依托单位:
In vivo analysis of EGFR mutant driven lung cancers responses to radiation therap
-
批准号:8450878
-
项目类别:
-
资助金额:$26.53万
-
财政年份:2006
-
负责人:Kwok Kin Wong
-
依托单位:
In vivo analysis of EGFR mutant driven lung cancers responses to radiation therap
-
批准号:8826566
-
项目类别:
-
资助金额:$28.22万
-
财政年份:2006
-
负责人:Kwok Kin Wong
-
依托单位:
Dysfunctional Telomeres, Checkpoints and Aging
-
批准号:7484951
-
项目类别:
-
资助金额:$27.08万
-
财政年份:2006
-
负责人:Kwok Kin Wong
-
依托单位:
EGFRvIII Mutation in Tumorigenesis and Sensitivity to Tyrosine Kinase Inhibitors
-
批准号:7428779
-
项目类别:
-
资助金额:$27.76万
-
财政年份:2006
-
负责人:Kwok Kin Wong
-
依托单位:
EGFRvIII Mutation in Tumorigenesis and Sensitivity to Tyrosine Kinase Inhibitors
-
批准号:7269241
-
项目类别:
-
资助金额:$27.76万
-
财政年份:2006
-
负责人:Kwok Kin Wong
-
依托单位:
EGFRvIII Mutation in Tumorigenesis and Sensitivity to Tyrosine Kinase Inhibitors
-
批准号:7130431
-
项目类别:
-
资助金额:$28.55万
-
财政年份:2006
-
负责人:Kwok Kin Wong
-
依托单位:
EGFRvIII Mutation in Tumorigenesis and Sensitivity to Tyrosine Kinase Inhibitors
-
批准号:7837568
-
项目类别:
-
资助金额:$27.76万
-
财政年份:2006
-
负责人:Kwok Kin Wong
-
依托单位:
EGFRvIII Mutation in Tumorigenesis and Sensitivity to Tyrosine Kinase Inhibitors
-
批准号:7621014
-
项目类别:
-
资助金额:$27.76万
-
财政年份:2006
-
负责人:Kwok Kin Wong
-
依托单位:
In vivo analysis of EGFR mutant driven lung cancers responses to radiation therap
-
批准号:8640891
-
项目类别:
-
资助金额:$27.38万
-
财政年份:2006
-
负责人:Kwok Kin Wong
-
依托单位:
Dysfunctional Telomeres, Checkpoints and Aging
-
批准号:7289887
-
项目类别:
-
资助金额:$27.72万
-
财政年份:2006
-
负责人:Kwok Kin Wong
-
依托单位:
Dysfunctional Telomeres, Checkpoints and Aging
-
批准号:7065017
-
项目类别:
-
资助金额:$28.63万
-
财政年份:2006
-
负责人:Kwok Kin Wong
-
依托单位:
Dysfunctional Telomeres, Checkpoints and Aging
-
批准号:7910424
-
项目类别:
-
资助金额:$26.63万
-
财政年份:2006
-
负责人:Kwok Kin Wong
-
依托单位:
In vivo analysis of EGFR mutant driven lung cancers responses to radiation therap
-
批准号:8108668
-
项目类别:
-
资助金额:$28.22万
-
财政年份:2006
-
负责人:Kwok Kin Wong
-
依托单位:
In vivo analysis of EGFR mutant driven lung cancers responses to radiation therap
-
批准号:8332284
-
项目类别:
-
资助金额:$28.22万
-
财政年份:2006
-
负责人:Kwok Kin Wong
-
依托单位:
Modeling Lung Cancer in Telomerase Null Mice
-
批准号:6804430
-
项目类别:
-
资助金额:$12.61万
-
财政年份:2003
-
负责人:Kwok Kin Wong
-
依托单位:
Modeling Lung Cancer in Telomerase Null Mice
-
批准号:6945778
-
项目类别:
-
资助金额:$12.61万
-
财政年份:2003
-
负责人:Kwok Kin Wong
-
依托单位:
Modeling Lung Cancer in Telomerase Null Mice
-
批准号:6617124
-
项目类别:
-
资助金额:$12.61万
-
财政年份:2003
-
负责人:Kwok Kin Wong
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: